BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cha YJ, Park Q, Kang ES, Yoo BC, Park KU, Kim JW, Hwang YS, Kim MH. Performance evaluation of the OraQuick hepatitis C virus rapid antibody test. Ann Lab Med. 2013;33:184-189. [PMID: 23667844 DOI: 10.3343/alm.2013.33.3.184] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen B, Ma ZH, Xu B, Chang H, He XX, Pei LJ, Ren YN, Xing WG. Evaluation of seven rapid diagnostic tests for detection of hepatitis C virus antibodies in China. J Viral Hepat 2021;28:657-63. [PMID: 33421262 DOI: 10.1111/jvh.13466] [Reference Citation Analysis]
2 Mahajan S, Agarwal R, Rawat V, Kumar G, Sharma MK, Gupta E. Comparative evaluation of three rapid immunochromatographic test assays with chemiluminescent microparticle immunoassay for the detection of hepatitis C virus antibody. Virusdisease 2019;30:373-9. [PMID: 31803804 DOI: 10.1007/s13337-019-00542-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
3 Buchanan R, Meskarian R, van der Heijden P, Grellier L, Parkes J, Khakoo SI. Prioritising Hepatitis C treatment in people with multiple injecting partners maximises prevention: A real-world network study. J Infect 2020;80:225-31. [PMID: 31887323 DOI: 10.1016/j.jinf.2019.12.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
4 Chionne P, Madonna E, Villano U, Tritarelli E, Pisani G, Costantino A, Equestre M, Marcantonio C, Bruni R, Ciccaglione AR. Sensitivity of hepatitis C virus rapid tests in detecting antibodies in general population. Panminerva Med 2020;62:125-30. [PMID: 31692308 DOI: 10.23736/S0031-0808.19.03678-4] [Reference Citation Analysis]
5 Rose CE, Duncan L, Hawes AM. Validation of OraQuick HCV Rapid Antibody Test in Postmortem Specimens. Acad Forensic Pathol 2020;10:81-6. [PMID: 33282041 DOI: 10.1177/1925362120957521] [Reference Citation Analysis]
6 Yang RF, Liu Y, Zhao CY, Ding YX, Chen Y, Wang YD, Duan ZP. A novel point-of-care oral anti-HCV assay: Is it reliable for screening hepatitis C virus infection in the era of direct-acting antivirals? PLoS One 2019;14:e0211795. [PMID: 30753207 DOI: 10.1371/journal.pone.0211795] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Saab S, Le L, Saggi S, Sundaram V, Tong MJ. Toward the elimination of hepatitis C in the United States. Hepatology 2018;67:2449-59. [PMID: 29181853 DOI: 10.1002/hep.29685] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
8 Avramovic G, Reilly M, Cullen W, Macías J, McCombe G, McHugh T, Oprea C, Story A, Surey J, Sabin C, Bivegete S, Vickerman P, Walker J, Ward Z, Lambert JS. HEPCARE EUROPE- A case study of a service innovation project aiming at improving the elimination of HCV in vulnerable populations in four European cities. Int J Infect Dis 2020;101:374-9. [PMID: 32992012 DOI: 10.1016/j.ijid.2020.09.1445] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 de Almeida Ribeiro CR, Amado LA, Tourinho RS, Pinto Lima LR, Melgaço JG, de Almeida AJ, Bastos LS, Lewis-Ximenez LL, de Paula VS. Accuracy of rapid test for diagnosis of hepatitis A with different infection rate settings and with predictive modeling. Future Microbiol 2019;14:247-58. [PMID: 30663895 DOI: 10.2217/fmb-2018-0211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Pai NP, Dhurat R, Potter M, Behlim T, Landry G, Vadnais C, Rodrigues C, Joseph L, Shetty A. Will a quadruple multiplexed point-of-care screening strategy for HIV-related co-infections be feasible and impact detection of new co-infections in at-risk populations? Results from cross-sectional studies. BMJ Open 2014;4:e005040. [PMID: 25510882 DOI: 10.1136/bmjopen-2014-005040] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
11 Scalioni Lde P, Cruz HM, de Paula VS, Miguel JC, Marques VA, Villela-Nogueira CA, Milagres FA, Cruz MS, Bastos FI, Andrade TM. Performance of rapid hepatitis C virus antibody assays among high- and low-risk populations. J Clin Virol. 2014;60:200-205. [PMID: 24794796 DOI: 10.1016/j.jcv.2014.04.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
12 Narayanamurthy V, Jeroish ZE, Bhuvaneshwari KS, Samsuri F. Hepatitis C virus (HCV) diagnosis via microfluidics. Anal Methods 2021;13:740-63. [PMID: 33511975 DOI: 10.1039/d0ay02045a] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Hagen RM, Wulff B, Loderstaedt U, Fengler I, Frickmann H, Schwarz NG, Polywka S. Is rapid hepatitis C virus testing from corpses a screening option for index persons who have died after mass-casualty incidents in high-prevalence settings in the field? J R Army Med Corps 2014;160:226-31. [PMID: 24113204 DOI: 10.1136/jramc-2013-000133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Khuroo MS, Khuroo NS, Khuroo MS. Diagnostic accuracy of point-of-care tests for hepatitis C virus infection: a systematic review and meta-analysis. PLoS One. 2015;10:e0121450. [PMID: 25816332 DOI: 10.1371/journal.pone.0121450] [Cited by in Crossref: 63] [Cited by in F6Publishing: 49] [Article Influence: 9.0] [Reference Citation Analysis]
15 Majem B, Rigau M, Reventós J, Wong DT. Non-coding RNAs in saliva: emerging biomarkers for molecular diagnostics. Int J Mol Sci 2015;16:8676-98. [PMID: 25898412 DOI: 10.3390/ijms16048676] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 6.0] [Reference Citation Analysis]
16 Kalichman SC, Hernandez D, Finneran S, Price D, Driver R. Transgender women and HIV-related health disparities: falling off the HIV treatment cascade. Sex Health 2017;14:469-76. [PMID: 28870282 DOI: 10.1071/SH17015] [Cited by in Crossref: 33] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
17 Pisanic N, Rahman A, Saha SK, Labrique AB, Nelson KE, Granger DA, Granger SW, Detrick B, Heaney CD. Development of an oral fluid immunoassay to assess past and recent hepatitis E virus (HEV) infection. J Immunol Methods 2017;448:1-8. [PMID: 28478117 DOI: 10.1016/j.jim.2017.04.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
18 Shahid I, Alzahrani AR, Al-Ghamdi SS, Alanazi IM, Rehman S, Hassan S. Hepatitis C Diagnosis: Simplified Solutions, Predictive Barriers, and Future Promises. Diagnostics (Basel) 2021;11:1253. [PMID: 34359335 DOI: 10.3390/diagnostics11071253] [Reference Citation Analysis]
19 Prabdial-Sing N, Gaelejwe L, Makhathini L, Thaver J, Manamela MJ, Malfeld S, Spearman CW, Sonderup M, Scheibe A, Young K, Hausler H, Puren AJ. The performance of hepatitis C virus (HCV) antibody point-of-care tests on oral fluid or whole blood and dried blood spot testing for HCV serology and viral load among individuals at higher risk for HCV in South Africa. Health Sci Rep 2021;4:e229. [PMID: 33614978 DOI: 10.1002/hsr2.229] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Houri I, Horowitz N, Katchman H, Weksler Y, Miller O, Deutsch L, Shibolet O. Emergency department targeted screening for hepatitis C does not improve linkage to care. World J Gastroenterol 2020; 26(32): 4878-4888 [PMID: 32921964 DOI: 10.3748/wjg.v26.i32.4878] [Reference Citation Analysis]
21 Gao F, Talbot EA, Loring CH, Power JJ, Dionne-Odom J, Alroy-Preis S, Jackson P, Bean CL. Performance of the OraQuick HCV rapid antibody test for screening exposed patients in a hepatitis C outbreak investigation. J Clin Microbiol 2014;52:2650-2. [PMID: 24789176 DOI: 10.1128/JCM.00132-14] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
22 Mukherjee R, Burns A, Rodden D, Chang F, Chaum M, Garcia N, Bollipalli N, Niemz A. Diagnosis and Management of Hepatitis C Virus Infection. J Lab Autom 2015;20:519-38. [PMID: 25609256 DOI: 10.1177/2211068214563794] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
23 Isho NY, Kachlic MD, Marcelo JC, Martin MT. Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center. J Am Pharm Assoc (2003) 2017;57:S259-64. [PMID: 28506379 DOI: 10.1016/j.japh.2017.03.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
24 Warkad SD, Song KS, Pal D, Nimse SB. Developments in the HCV Screening Technologies Based on the Detection of Antigens and Antibodies. Sensors (Basel) 2019;19:E4257. [PMID: 31575036 DOI: 10.3390/s19194257] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
25 Handanagic S, Sevic S, Barbaric J, Dominkovic Z, Dakovic Rode O, Begovac J, Bozicevic I. Correlates of anti-hepatitis C positivity and use of harm reduction services among people who inject drugs in two cities in Croatia. Drug Alcohol Depend 2017;171:132-9. [PMID: 28088084 DOI: 10.1016/j.drugalcdep.2016.11.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
26 Vandegrift KJ, Critchlow JT, Kapoor A, Friedman DA, Hudson PJ. Peromyscus as a model system for human hepatitis C: An opportunity to advance our understanding of a complex host parasite system. Semin Cell Dev Biol 2017;61:123-30. [PMID: 27498234 DOI: 10.1016/j.semcdb.2016.07.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
27 Alimohammadi A, Holeksa J, Parsons R, Yung R, Amiri N, Truong D, Conway B. Diagnosis and treatment of hepatitis C virus infection: a tool for engagement with people who inject drugs in Vancouver’s Downtown Eastside. CanLivJ 2018;1:14-33. [DOI: 10.3138/canlivj.1.2.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
28 Carvalho-Gomes Â, Cubells A, Pallarés C, Hontangas V, Conde I, Di Maira T, Peiró S, Sanfélix-Gimeno G, López-Labrador FX, Berenguer M. A population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area. PLoS One 2020;15:e0228351. [PMID: 32045417 DOI: 10.1371/journal.pone.0228351] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
29 Kalichman SC, Washington C, Kegler C, Grebler T, Kalichman MO, Cherry C, Eaton L. Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy. Subst Use Misuse 2015;50:1536-43. [PMID: 26583598 DOI: 10.3109/10826084.2015.1023451] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
30 Park SM, Sabour AF, Son JH, Lee SH, Lee LP. Toward integrated molecular diagnostic system (i MDx): principles and applications. IEEE Trans Biomed Eng 2014;61:1506-21. [PMID: 24759281 DOI: 10.1109/TBME.2014.2309119] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
31 Liu L, Zhang M, Hang L, Kong F, Yan H, Zhang Y, Feng X, Gao Y, Wang C, Ma H, Liu X, Zhan M, Pan Y, Xu H, Niu J. Evaluation of a new point-of-care oral anti-HCV test for screening of hepatitis C virus infection. Virol J 2020;17:14. [PMID: 32005264 DOI: 10.1186/s12985-020-1293-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
32 Sonderup MW, Afihene M, Ally R, Apica B, Awuku Y, Cunha L, Dusheiko G, Gogela N, Lohouès-kouacou M, Lam P, Lesi O, Mbaye PS, Musabeyezu E, Musau B, Ojo O, Rwegasha J, Scholz B, Shewaye AB, Tzeuton C, Kassianides C, Spearman CW. Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030. The Lancet Gastroenterology & Hepatology 2017;2:910-9. [DOI: 10.1016/s2468-1253(17)30249-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
33 Young AM, Stephens DB, Khaleel HA, Havens JR. Hepatitis C vaccine clinical trials among people who use drugs: potential for participation and involvement in recruitment. Contemp Clin Trials. 2015;41:9-16. [PMID: 25553715 DOI: 10.1016/j.cct.2014.12.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
34 Beckwith CG, Kurth AE, Bazerman LB, Patry EJ, Cates A, Tran L, Noska A, Kuo I. A pilot study of rapid hepatitis C virus testing in the Rhode Island Department of Corrections. J Public Health (Oxf) 2016;38:130-7. [PMID: 25736438 DOI: 10.1093/pubmed/fdv023] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
35 Saab S, Viramontes MR, Chalifoux SL, Craw CJ, Ramirez SD, Bau SN, Arevalo DG, Saab EG, Saab CE, Craw CS, Estafanous A, Messiah R, Messiah W, El Kabany M. Hepatitis C Virus Prevalence in Egyptian Americans in Southern California. J Clin Gastroenterol 2018;52:55-9. [PMID: 28617761 DOI: 10.1097/MCG.0000000000000858] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Andries AC, Duong V, Ong S, Ros S, Sakuntabhai A, Horwood P, Dussart P, Buchy P. Evaluation of the performances of six commercial kits designed for dengue NS1 and anti-dengue IgM, IgG and IgA detection in urine and saliva clinical specimens. BMC Infect Dis 2016;16:201. [PMID: 27184801 DOI: 10.1186/s12879-016-1551-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
37 Tang W, Chen W, Amini A, Boeras D, Falconer J, Kelly H, Peeling R, Varsaneux O, Tucker JD, Easterbrook P. Diagnostic accuracy of tests to detect Hepatitis C antibody: a meta-analysis and review of the literature. BMC Infect Dis 2017;17:695. [PMID: 29143615 DOI: 10.1186/s12879-017-2773-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 10.2] [Reference Citation Analysis]
38 Easterbrook PJ; WHO Guidelines Development Group. Who to test and how to test for chronic hepatitis C infection - 2016 WHO testing guidance for low- and middle-income countries. J Hepatol 2016;65:S46-66. [PMID: 27641988 DOI: 10.1016/j.jhep.2016.08.002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 16.5] [Reference Citation Analysis]
39 Gonçalves Lda R, Campanhon IB, Domingues RR, Paes Leme AF, Soares da Silva MR. Comparative salivary proteome of hepatitis B- and C-infected patients. PLoS One 2014;9:e113683. [PMID: 25423034 DOI: 10.1371/journal.pone.0113683] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
40 Swan D, Cullen W, Macias J, Oprea C, Story A, Surey J, Vickerman P, Lambert JS. Hepcare Europe - bridging the gap in the treatment of hepatitis C: study protocol. Expert Rev Gastroenterol Hepatol 2018;12:303-14. [PMID: 29300496 DOI: 10.1080/17474124.2018.1424541] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
41 Kalichman SC, Kalichman MO, Cherry C, Hoyt G, Washington C, Grebler T, Welles B, Merely C. Intentional Medication Nonadherence Because of Interactive Toxicity Beliefs Among HIV-Positive Active Drug Users. J Acquir Immune Defic Syndr 2015;70:503-9. [PMID: 26226250 DOI: 10.1097/QAI.0000000000000776] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
42 Setyowati D, Mubawadi T, Mirasa YA, Purwanto D, Amin M, Utsumi T, Soetjipto S, Juniastuti J, Lusida MI. Molecular epidemiology of hepatitis A outbreaks in two districts in Indonesia in 2018: Same subtype, but different strains. Biomed Rep 2020;12:51-8. [PMID: 31929874 DOI: 10.3892/br.2019.1261] [Reference Citation Analysis]
43 Jang MA, Kim B, Lee YK. Reporting Quality of Diagnostic Accuracy Studies in Laboratory Medicine: Adherence to Standards for Reporting of Diagnostic Accuracy Studies (STARD) 2015. Ann Lab Med 2020;40:245-52. [PMID: 31858765 DOI: 10.3343/alm.2020.40.3.245] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Lacroix N, Barraud H, Gillet C, Di Patrizio P, Bronowicki JP, Schwan R, Laprévote V. [Which place for point-of-care screening tests in the diagnosis of hepatitis C infection among drug users?]. Presse Med 2016;45:431-7. [PMID: 26947910 DOI: 10.1016/j.lpm.2016.01.024] [Reference Citation Analysis]